The
global clinical
nutrition market was valued at $39,339.4 million
in 2015, and it is expected to grow at a CAGR of 5.4% during 2016 - 2022. The
factors driving the growth of the global market include increasing geriatric
population, high birth rate and high number of premature birth, surge in the
number of victims of malnutrition receiving treatment, surging incidence of
lifestyle associated disease, and increasing incidence of cancer and central
nervous system diseases. Malnutrition is a widespread problem, affecting the
lives of millions of people globally. It is a condition that occurs due to
deficiency of essential nutrients in the body. In 2010, around 40% of all
hospital patients globally were malnourished. Clinical nutrition is the most
efficient way to treat malnutrition and helps in avoiding associated costs. In
Europe, around one-third of all hospital patients were malnourished in 2012. The
increase in the number of victims of malnutrition globally, is expected to
result in an increased usage of healthcare resource due to the longer stays in
hospitals. As per an article of 2012, the malnutrition cost European government
up to USD 237.0 billion a year; while the clinical nutrition accounted for about
2.5% of the cost involved with malnutrition.
The
increasing incidence of cancer and central nervous system (CNS) diseases is
driving the growth of the global enteral nutrition market. Enteral nutrition
products are considered to be one of the best alternatives during the treatment
of cancer and CNS diseases, to avoid nutrition deficiency in human body, for
optimal functioning of various organs. Cancer can change the metabolism of
nutrient uptake in patient’s body, therefore they require good nutrition.
Cancer may lead to malnutrition and weight loss; therefore, patients are
required continuous nutrient feeding. Enteral nutrition is one of the best
solutions to the problem. According to the WHO, there were 14.1 million new
cancer cases, 8.2 million cancer deaths and 32.6 million people living with
cancer (within 5 years of diagnosis) in 2012 globally. The organization also
reported that 57% (8 million) of new cancer cases, 65% (5.3 million) of the
cancer deaths and 48% (15.6 million) of the 5-year prevalent cancer cases
occurred in the less developed regions.
Ask for Report Sample: https://www.psmarketresearch.com/market-analysis/clinical-nutrition-market/report-sample
Some of the major players
operating in the global clinical nutrition market include Baxter International
Inc., Abbott Laboratories, B. Braun Melsungen AG, Nestlé S.A., Groupe Danone, Mead
Johnson Nutrition Company, Fresenius Kabi AG, and Perrigo Company Plc.
About P&S Market Research
P&S Market Research is a
market research company, which offers market research and consulting services
for various geographies around the globe. We provide market research reports,
industry forecasting reports, business intelligence, and research based
consulting services across different industry/business verticals.
As one of the top growing
market research agency, we’re keen upon providing market landscape and accurate
forecasting. Our analysts and consultants are proficient with business
intelligence and market analysis, through their interaction with leading
companies of the concerned domain. We help our clients with B2B market research
and assist them in identifying various windows of opportunity, and framing
informed and customized business expansion strategies in different regions.
Contact:
Abhishek
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Web: https://www.psmarketresearch.com
No comments:
Post a Comment